NTRK2 and central nervous system cancer: As an internal control, TrkB.T1 immunostaining was negative in human glioma stromal blood vessels (Supplementary Fig. 4c) and TrkB.T1-/- mouse cortex (Fig. 4c and Supplementary Fig. 5a).